GlaxoSmithKline PLC Director/PDMR Shareholding (5083U)
29 Luglio 2020 - 3:02PM
UK Regulatory
TIDMGSK
RNS Number : 5083U
GlaxoSmithKline PLC
29 July 2020
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Sir Jonathan Symonds
==== ======================================== =================================================
b) Position/status Non-Executive Chairman
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== =================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 April 2020 to 30 June
2020.
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
GBP15.89 2,753.304
=================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ ==============================
e) Date of the transaction 2020-07-29
==== ======================================== =================================================
f) Place of the N/A
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Mr Charles Bancroft
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 April 2020 to 30 June 2020.
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$40.82 500.844
======================= =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2020-07-29
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Mr Vindi Banga
==== ======================================== =================================================
b) Position/status Senior Independent Non-Executive Director
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== =================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 April 2020 to 30 June
2020.
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
GBP15.89 570.327
=================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ ==============================
e) Date of the transaction 2020-07-29
==== ======================================== =================================================
f) Place of the N/A
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Dr Vivienne Cox
==== ======================================== =================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== =================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 April 2020 to 30 June
2020.
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
GBP15.89 688.326
=================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ ==============================
e) Date of the transaction 2020-07-29
==== ======================================== =================================================
f) Place of the N/A
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Ms Lynn Elsenhans
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 April 2020 to 30 June 2020.
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$40.82 650.632
======================= =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2020-07-29
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Dr Laurie Glimcher
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 April 2020 to 30 June 2020.
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$40.82 1,222.400
======================= =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2020-07-29
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Dr Jesse Goodman
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 April 2020 to 30 June 2020.
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$40.82 384.465
======================= =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2020-07-29
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Ms Judy Lewent
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 April 2020 to 30 June 2020.
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$40.82 404.181
======================= =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2020-07-29
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Mr Urs Rohner
==== ======================================== =================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== =================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 April 2020 to 30 June
2020.
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
GBP15.89 530.994
=================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ ==============================
e) Date of the transaction 2020-07-29
==== ======================================== =================================================
f) Place of the N/A
transaction
==== ======================================== =================================================
, the news service of the London Stock Exchange. RNS is approved by
the Financial Conduct Authority to act as a Primary Information
Provider in the United Kingdom. Terms and conditions relating to
the use and distribution of this information may apply. For further
information, please contact rns@lseg.com or visit www.rns.com.
DSHXKLFLBDLBBBB
(END) Dow Jones Newswires
July 29, 2020 09:02 ET (13:02 GMT)
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Apr 2023 a Apr 2024
